Cookie Policy

A full description of our cookie policy can be found here.

Essential (Required)

Cookies that the site cannot function without. This includes cookies for access to secure areas and CSRF protection. Please note that Craft's default cookies do not collect any personal or sensitive information. Craft's default cookies do not collect IP addresses. The information they store is not sent to Pixel & Tonic or any 3rd parties.

Name: CraftSessionId
Description: Craft relies on PHP sessions to maintain sessions across web requests. That is done via the PHP session cookie. Craft names that cookie “CraftSessionId” by default, but it can be renamed via the phpSessionName config setting. This cookie will expire as soon as the session expires.
Provider: biocatalysts.com
Expiry: Session

Name: *_identity
Description: When you log into the control panel, you’ll get an authentication cookie used to maintain your authenticated state. The cookie name is prefixed with a long, randomly generated string, followed by _identity. The cookie only stores information necessary to maintain a secure, authenticated session and will only exist for as long as the user is authenticated in Craft.
Provider: biocatalysts.com
Expiry: Persistent

Name: *_username
Description: If you check the "Keep me logged in" option during login, this cookie is used to remember the username for your next authentication.
Provider: biocatalysts.com
Expiry: Persistent

Name: CRAFT_CSRF_TOKEN
Description: Protects us and you as a user against Cross-Site Request Forgery attacks.
Provider: biocatalysts.com
Expiry: Session

Media and Resources

Application Solutions, Case Studies, News, Events: here you find resources related to your industry sector, and where to meet us at events coming soon.

Home/ Media & Resources

Search & filter articles

21 Articles

2 Mar 2023

Biocatalysts Ltd launch Nuclease for the growing precision fermentation market

Nuclease 46L has been designed specifically as a cost-effective solution for the elimination of nucleic acids in a wide range of biotechnology applications.

BRAIN Biotech AG Capital Markets Day 2023 high res

27 Feb 2023

BRAIN Biotech AG to build an international multi-niche enzyme and food ingredients champion

With the enzyme activities of the group focusing on food, beverage and healthcare, combined with BRAIN Biotech's strong scientific roots, the Group are well positioned to service global megatrends from the production of better and healthier foods to sustainable industrialisation.

BRAIN Biotech Annual Report 21 22 Cover low res KL

16 Jan 2023

BRAIN Biotech AG reports record figures in fiscal year 2021/22

Despite a challenging geopolitical environment, BRAIN Biotech announce strong sales laying the foundations for ongoing future dynamic growth.

18 Nov 2022

Biocatalysts awarded in Top 10 Synthetic Biology Companies 2022 by Life Sciences Review!

We're very pleased to receive this esteemed award from Life Sciences Review in their annual listing of 10 companies that are at the forefront of providing Synthetic Biology solutions and transforming businesses.

25 Jul 2022

Precision Fermentation – a bio-based route to alternative protein

Nutrition in industrialised countries will move away from meat and dairy consumption towards alternative sources of protein and foods. These will rely on plants, microorganisms and cell cultures. Biotechnology will be the key enabler. This is where we come in.

Biocatalysts Ltd 2021 EMP Feed Tanks Copyrighted 2

14 Oct 2021

Biocatalysts Ltd Announce Plans for Further Investment for Second 10m³ Fermenter in Cardiff

The introduction of a second 10m³ fermenter enables Biocatalysts Ltd.’s manufacturing site in Cardiff to act as a pilot plant for medium-scale production and optimised tech-transfer for larger industrial scale fermentation.

Case Study

Novel enzyme used in carbohydrate modification produced in partnership with sugar reduction company.

Working in close partnership we were able to rapidly scale up their process to produce the enzyme at commercial volumes enabling them to reduce the time to market for their unique offering into this exciting fast-moving sector.

11 Aug 2021

Project Completion & Successful Commissioning of Biocatalysts Ltd's New Enzyme Manufacturing Facility

Operations Director, Craig Galeozzie provides a final update following the successful project completion and commissioning of the new state-or-the-art enzyme manufacturing facility.

13 May 2021

Biocatalysts Ltd First Commercial Production in New Enzyme Manufacturing Facility

Key milestone achieved with the first product fermented and processed in the state-of-the-art enzyme manufacturing facility is delivered to the customer.

Case Study

Introducing a NEW Expression Host – Yarrowia lipolytica

Expression strain developments increase Biocatalysts' enzyme development and manufacture service offering

4 Nov 2020

Winners of Prestigious IChemE Global Food & Drink Award 2020

IChemE have selected Biocatalysts Ltd in partnership with University College London (UCL) as the winners of the prestigious IChemE Global Food & Drink Award 2020, for our submission – Ultra Scale-Down Accelerates Industrial Enzyme Manufacture.

Case Study

Partnering with a Global Pharmaceutical Company for Large Scale Enzyme Manufacturing

A large pharmaceutical company needed an enzyme manufacturing partner to develop their enzymes from lab to commercial scales.